###### Article summary

Article focus
=============

-   This study aimed to examine the difference in attitudes towards specialist care for teenage and young adult (TYA) patients with cancer among those involved in their care in an attempt to quantify the variation.

Key messages
============

-   A wide range of attitudes towards specialist care is seen in those involved in the care of TYA patients with cancer.

-   Three distinct groups of opinion exist, with each favouring a different aspect of care: age specific, cancer site specific or a combination of both.

Strengths and limitations of this study
=======================================

-   This is the first study of its kind to examine attitudes towards specialist care for TYA patients with cancer, and responses were received from a wide range of professionals with varying degrees of contact with TYA patients.

-   Random sampling may have introduced bias, which is unavoidable using this methodology; however, results suggest that this was not a significant problem in this study.

-   Further work would allow for responses from a wider study population and more in-depth examination of areas of disagreement.

Introduction {#s1}
============

The incidence of cancer in teenagers and young adults (TYA) is rare compared with that in older adults.[@R1] In recent years, only around 2000 cases have been diagnosed annually in patients aged between 15 and 24;[@R1] [@R2] thus, its optimal management poses a major challenge to healthcare providers.

Challenges include not only the wide spectrum of cancers experienced by this age group but also the host and disease biology of these tumours, which can differ from that seen in both children and adults.[@R3; @R4; @R5; @R6] Likewise, individuals in this age group also have very different psychosocial needs to either adults or children.[@R7; @R8; @R9] The optimal setting to meet these biological and psychosocial needs is, therefore, not ideally managed by adult or children\'s cancer teams, but by a TYA-specialist team drawing expertise from both professional groups. The widely varying spectrum of cancers affecting this age group and their unusual position in terms of age-focused services has led many to argue in favour of specialist care.[@R10; @R11; @R12] However, owing to the different age-specific and cancer-specific care needs involved, there is, as yet, no consensus on what constitutes such 'specialist' care.[@R10] [@R12; @R13; @R14]

Access to tumour-specialist multidisciplinary teams (MDTs), age-specialist MDTs and specialist diagnostic services, clinical trials and specialist supportive services have all been cited as crucial to optimal outcomes in tumour site-specific guidelines (National Institute for Health and Clinical Excellence cancer service guidelines[@R11]). Other guidelines place more emphasis on the importance of age-specific services and the availability of psychosocial and late effects supportive care.[@R15] Principal treatment centres (PTC) have been advocated where patients have access to specialist environments of care, as were appropriately trained professionals from both site-specific and age-specific teams working together closely. A larger degree of specialisation than other cancer units has been supported. Three different types of PTC exist with three different foci: TYA-specific (teenage cancer trust (TCT) unit),[@R16] paediatric (Children\'s Cancer and Leukaemia Group (CCLG) unit)[@R17] and cancer site-specific units.[@R18] In some cases, a single centre may include all three types of specialist units.

There is known variation in where, how and by whom TYA patients with cancer are treated.[@R19] [@R20] What is not fully understood is whether this is due to the availability of services (both geographically and age wise), patient\'s choice or physician\'s decision. Understanding the attitudes of those who treat this age range is vital to gaining a clearer insight into the key components of care of this age group, and therefore determining to what extent varying attitudes may be influencing the variation in treatment.

Policy states that treatment at a PTC is a key part of the cancer treatment pathway, as is access to clinical trials, MDT follow-up, age and cancer site appropriate care.[@R11] The latter has not been examined in detail, and therefore this study aimed to examine the variation in attitudes towards specialist care for TYA patients among those involved in the treatment of this group, and to determine whether opinion mirrored policy. It also aimed to quantify any variation noted and to establish whether this was associated with specific characteristics of the respondents such as job title, type of centre and caseload.

Participants and methods {#s2}
========================

Sample selection {#s2a}
----------------

A list of healthcare professionals from National Health Service (NHS) trusts across the UK (England, Scotland, Wales and Northern Ireland) involved in the treatment of TYA patients were identified using NHS trust websites. Individuals, including doctors, nurses and other health professionals, such as radiographers and physiotherapists, with a specialty which involved the care of patients with cancer and whose contact details were available on the NHS trust website, were included. Email addresses were freely available for 98 trusts in the UK at the time of this study. Each individual was contacted by email during June 2009 and asked to complete the questionnaire and to forward it to others to whom it might have been of interest. Non-responders received two follow-up emails between December 2009 and February 2010.

Survey development and study protocol {#s2b}
-------------------------------------

The survey consisted of a list of statements ([table 1](#BMJOPEN2012002346TB1){ref-type="table"}) about factors that had been identified in the medical literature as being potentially important features of specialist TYA cancer care.[@R10] [@R12] [@R19] [@R21; @R22; @R23; @R24; @R25] The statements encompassed both age-appropriate and site-specific features of care alongside more general aspects of cancer services. Respondents were asked to rate these 27 statements using a Likert scale (1---low importance to 5---high importance). Questions regarding the age range that respondents deemed appropriate for TYA patients, respondent\'s specialty and affiliation with a TCT unit were also included.

###### 

Responses

  Rank   Q    4 or higher   3      2 or lower   Missing   Question                       
  ------ ---- ------------- ------ ------------ --------- ---------- ------ ----- ------ -------------------------------------------------------------------------------------------------------------------------------
  1      16   314           92.9   10           3.0       8          2.4    6     1.8    Psychological and psychosocial support from those specialising in the care of teenagers and young adults.
  2      14   314           92.9   11           3.3       8          2.4    5     1.5    Contact with a nurse specialising in the care of teenagers and young adults.
  3      13   303           89.6   18           5.3       13         3.8    4     1.2    Treatment in an age-appropriate environment.
  4      1    289           85.5   32           9.5       13         3.8    4     1.2    Treatment by a site-specific surgical or medical team.
  5      12   286           84.6   34           10.1      13         3.8    5     1.5    Access to age-appropriate clinical trials.
  6      21   285           84.3   32           9.5       18         5.3    3     0.9    Contact with peers who have undergone or are undergoing similar treatments or who have been diagnosed with the same illness.
  7      6    285           84.3   38           11.2      10         3.0    5     1.5    Regular follow-up by a site-specific MDT.
  8      5    285           84.3   40           11.8      6          1.8    7     2.1    Contact with a site-specific clinical nurse specialist or Macmillan nurse.
  9      3    284           84.0   39           11.5      12         3.6    3     0.9    Access to site-specific clinical trials.
  10     2    282           83.4   39           11.5      13         3.8    4     1.2    Diagnostics and staging by site-specialist clinical teams (radiology, pathology, etc)
  11     10   256           75.7   44           13.0      34         10.1   4     1.2    Treatment by a medical or surgical team who specialise in the treatment and care of teenagers and young adults.
  12     15   236           69.8   57           16.9      39         11.5   6     1.8    Regular follow-up by an age-specific MDT.
  13     19   230           68.0   74           21.9      27         8.0    7     2.1    Treatment at a high volume cancer centre.
  14     11   195           57.7   86           25.4      52         15.4   5     1.5    Diagnostics and staging by clinical teams specialising in the care of teenagers and young adults (radiology, pathology, etc).
  15     7    194           57.4   10           3.0       6          1.8    128   37.9   Psychological and psychosocial support from those specialising in the care of persons with cancer.
  16     26   192           56.8   10           3.0       3          0.9    133   39.3   Access to fertility specialists and advice on reproductive issues.
  17     17   188           55.6   12           3.6       5          1.5    133   39.3   Access to age-appropriate palliative care if needed.
  18     24   186           55.0   16           4.7       4          1.2    132   39.1   Support for family friends and partners of the patient.
  19     18   184           54.4   15           4.4       7          2.1    132   39.1   Access to age-appropriate end of treatment care and support and information on late effects of treatment.
  20     23   183           54.1   18           5.3       5          1.5    132   39.1   Educational and employment support during and after treatment.
  21     27   179           53.0   17           5.0       9          2.7    133   39.3   Ability to stay in contact with peers when in hospital, Facebook, email text messages, etc
  22     9    168           49.7   28           8.3       13         3.8    129   38.2   Access to site-specific end of treatment care and support and information on late effects of treatment.
  23     25   167           49.4   30           8.9       10         3.0    131   38.8   Treatment by the same team throughout.
  24     8    160           47.3   30           8.9       17         5.0    131   38.8   Access to site-specific palliative care if needed.
  25     22   141           41.7   43           12.7      22         6.5    132   39.1   Outpatient appointments held in an age-appropriate environment.
  26     20   129           38.2   116          34.3      86         25.4   7     2.1    Treatment at a hospital in close proximity to a patient\'s home address.
  27     4    114           33.7   90           26.6      128        37.9   6     1.8    Inpatient treatment on a site-specific ward (eg, breast).

MDT,multidisciplinary team.

Statistical analysis {#s2c}
--------------------

Descriptive statistics were used to describe demographics of respondents. Mann-Whitney tests were used to examine the difference between demographic information and the responses on the 5-point Likert scale.

Missing information was recorded as such in the analysis, as the proportion of respondents who left each question blank was considered an interesting outcome in its own right.

Model-based latent cluster analysis was used to establish underlying characteristics and relationships that could be used to group data into natural/latent classes. The Bayesian information criterion score was used to determine the number of latent classes which provided the best fit to the respondents' data. The analysis was performed using Stata 11 and Latent Gold 4.5.[@R27]

Results {#s3}
=======

Six hundred and ninety-one healthcare professionals from 98 NHS trusts were asked to complete the questionnaire and 338 (51.9%) responded. The characteristics of the respondents are detailed in [table 2](#BMJOPEN2012002346TB2){ref-type="table"}. In all, 253 (74.9%) were from England, 21 (6.2%) from Northern Ireland, 30 (8.9%) from Scotland and 34 (10.1%) from Wales. One hundred and ninety (56.2%) reported that they were affiliated with a teenage cancer unit and 208 (61.5%) were linked to a CCLG unit. The majority of respondents belonged to a medical rather than a surgical specialism (78.4% vs 21.6%, respectively). Over half of all those who responded (55.7%) reported that less than 10% of their annual workload comprised TYA patients and only 35 respondents (16.8%) reported seeing more than 20 TYA oncology patients annually. In total, 129 respondents (38.2%) failed to report the number of TYA patients treated annually; however, only 2 (0.6%) failed to report the proportion of their total caseload which consisted of TYA patients. The most frequently suggested lower age range for a TYA service was 13 (52.7%, range 11--19 years of age) and the most commonly (modal) recommended upper age limit was 25 (25.7%, range 16--40 years of age).

###### 

Characteristics of respondents

                                                     Cluster 1   Cluster 2   Cluster 3                         
  -------------------------------------------------- ----------- ----------- ----------- ------- ------ ------ -----
  Country                                                                                                      
   England                                           100         34.0        107         36.4    87     29.6   294
   Scotland                                          6           40.0        5           33.3    4      26.7   15
   Wales                                             5           27.8        9           50.0    4      22.2   18
   Northern Ireland                                  3           27.3        3           27.3    5      45.5   11
  Self-reported job title                                                                                      
   Doctor                                            99          42.3        69          29.5    66     28.2   234
   Nurse                                             9           14.1        36          56.3    19     29.7   64
   Radiographer                                      1           10.0        1           10.0    8      80.0   10
   Management                                        1           14.3        3           42.9    3      42.9   7
   Social worker                                     0           0.0         3           60.0    2      40.0   5
   Other                                             4           23.5        11          64.7    2      11.8   17
   Unknown                                           0           0.0         1           100.0   0      0.0    1
  Specialism                                                                                                   
   Medical                                           92          33.9        103         38.0    76     28.0   271
   Surgical                                          22          32.8        21          31.3    24     35.8   67
  Area of expertise                                                                                            
   Oncology                                          38          26.8        57          40.1    47     33.1   142
   Haematology                                       27          60.0        13          28.9    5      11.1   45
   Paediatrics                                       10          55.6        1           5.6     7      38.9   18
   Gynaecology                                       2           11.1        10          55.6    6      33.3   18
   ENT                                               8           50.0        6           37.5    2      12.5   16
   Palliative medicine                               4           26.7        10          66.7    1      6.7    15
   General surgery                                   3           21.4        4           28.6    7      50.0   14
   Radiology                                         0           0.0         3           30.0    7      70.0   10
   Other surgical specialty                          18          35.0        2           15.0    15     45.0   35
   Other non-surgical specialty                      6           42.9        5           35.7    4      21.4   15
   Other                                             6           42.9        14          35.7    6      21.4   26
  Type of specialist interest                                                                                  
   Age                                               9           18.4        15          30.6    25     51.0   49
   Site                                              79          39.3        72          35.8    50     24.9   201
   Both                                              26          29.9        36          41.4    25     28.7   87
   Unknown                                           0           0.0         1           100.0   0      0.0    1
  Teenage cancer unit                                                                                          
   Yes                                               58          30.5        83          43.7    49     25.8   190
   No                                                56          37.8        41          27.7    51     34.5   148
  CCLG unit                                                                                                    
   Yes                                               70          33.7        70          33.7    68     32.7   208
   No                                                44          33.8        54          41.5    32     24.6   130
  Number of TYA patients seen annually                                                                         
   0--5                                              43          44.3        28          28.9    26     26.8   97
   6--10                                             25          52.1        10          20.8    13     27.1   48
   11--15                                            3           16.7        8           44.4    7      38.9   18
   16--20                                            3           27.3        5           45.5    3      27.3   11
   21+                                               3           8.6         17          48.6    15     42.9   35
   Unknown                                           37          28.7        56          43.4    36     27.9   129
  Proportion of overall caseload consisting of TYA                                                             
   Less than 10%                                     87          46.3        47          25.0    54     28.7   188
   10--20%                                           14          26.9        23          44.2    15     28.8   52
   20--30%                                           6           19.4        11          35.5    14     45.2   31
   30--40%                                           4           26.7        9           60.0    2      13.3   15
   Greater than 40%                                  3           6.0         32          64.0    15     30.0   50
   Unknown                                           0           0.0         2           100.0   0      0.0    2
  Total                                                                                                        
  114                                                33.7        124         36.7        100     29.6   338    

CCLG, Children\'s Cancer and Leukaemia Group; TYA, teenage and young adult.

Many respondents also recorded that the patient range should not be restricted by age but by the diagnostic group and emotional maturity of the patient. The latent class model identified three clusters of respondents with specific attitudes concerning specialist care ([figure 1](#BMJOPEN2012002346F1){ref-type="fig"}).

![Cluster analysis of responses to the survey.](bmjopen2012002346f01){#BMJOPEN2012002346F1}

Cluster 3 rated the treatment by a site-specific team higher than an age-specialist team, but did not rate any of the statements as highly as clusters 1 and 2, indicating that individuals in cluster 3 answered more questions as being of neither high nor low importance.

Cluster 1 rated age-appropriate treatment very highly in all areas while cluster 2 rated most points highly and did not favour either age-specialist or site-specialist care. Overall, it appeared that clusters should be grouped as follows:

Cluster 1---Age-specific preference

Cluster 2---Combined age-specific and site-specific preference

Cluster 3---Cancer site-specific preference

The variation in responses between the three clusters was statistically significant for all questions (p≤0.01), with the exception of question 20 (p=0.61).

On further examination of the self-reported interests of the respondents ([table 2](#BMJOPEN2012002346TB2){ref-type="table"}), the distribution of those affiliated with a TCT or a CCLG unit was found to be even across the three clusters. The majority of individuals in cluster 3, which favoured site-specialist treatment, had a site-specific interest (eg, colorectal or breast surgery), and contained a greater proportion of those with a surgical specialty than any other cluster. Persons within cluster 2 treated the highest number of TYA cases annually, while cluster 1 treated the lowest, with 68 respondents reporting seeing fewer than 11 cases annually.

When the questions were ranked in order of importance, the three questions ranked mostly highly were ([table 1](#BMJOPEN2012002346TB1){ref-type="table"}): (1) psychological and psychosocial support from those specialising in the care of TYA (314 respondents (92.9%) marked as a 4 or higher); (2) contact with a nurse specialising in the care of TYA (314 respondents (92.9%) marked as a 4 or higher); and (3) treatment in an age-appropriate environment (303 respondents (89.6%) marked as a 4 or higher). The three statements ranked the lowest were: (1) inpatient treatment on a site-specific ward (eg, breast) (128 respondents (37.9%) marked as a 2 or lower); (2) treatment at a hospital in close proximity to a patient\'s home address (86 respondents (25.4%) marked as a 2 or lower); and (3) diagnostics and staging by clinical teams specialising in the care of teenagers and young adults (radiology, pathology, etc) (52 respondents (15.4% marked as a 2 or lower). The three statements which ranked the lowest also had the greatest number of indifferent responses (scored 3 on the Likert scale). Aspects of care often discussed as being key aspects of specialist care for TYA patients by patients themselves [@R8] ranked relatively low on the scale. Access to clinical trials, particularly site-specific, ranked around the middle of the table of ordered responses (ranked ninth most important). Treatment at a high volume cancer centre was also ranked of relatively low importance with only 230 respondents (68.0%) scoring this 4 or higher and 74 (21.9%) recording it as neither of high nor low importance.

Statements ranked 15th to 25th overall were unanswered in over 35% of cases. These questions related mainly to psychosocial support, palliative care and long-term follow-up. This was vastly different to the number of missing answers for other questions (range 3--7 missing answers). The focus of these questions may have led a greater proportion of respondents to leave them unanswered; previous studies have shown a patchy and irregular referral to supportive services, suggesting a greater degree of indifference than shown in the other areas addressed in the study.[@R27] [@R28]

Discussion {#s4}
==========

This study demonstrates widely varying opinions as to what is important in the care of TYA patients with cancer. Attitudes were divided into three categories: those who advocated age-appropriate care, those who preferred tumour-site-specialist care and those who promoted a combination of both age-specialist and site-specialist care. The characteristics of individuals in these three clusters were different, with specialism, caseload and involvement with either a TYA or a CCLG unit varying between groups. Aspects of care which are frequently the focus of policy, such as access to a high volume cancer centre and access to clinical trials, were assigned lower importance than expected, as were all aspects related to end of life care.

Current policy states that all patients in the TYA age range should at least be offered the opportunity to be treated at a PTC and to receive specialist care.[@R11] This study reflects the varying attitudes towards specialist care for this age group and illustrates the difficulties in fully implementing policy in relation to the differing degrees of importance associated to it. Where the rhetoric is not believed by all those involved in the diagnostic, treatment and support pathway for this patient group, and as long as flexibility remains, specialist TYA cancer care, as it is currently defined, will not be implemented consistently.

As a relatively young area of cancer treatment with a multitude of diagnoses and treatment options, the pathways and protocols for TYA cancer care are known to vary. Not all TYA patients are treated at TYA specialist units; in some cases, this may be due to patient choice, while in others it could be due to a lack of appropriate referral to the units. This variation alongside the disagreement as to what constitutes the key aspects of care for TYA with cancer may demonstrate the need for multidisciplinary involvement in order to ensure that patients receive the best of all elements of care. All the respondents to this survey were actively involved in the treatment of TYA patients but have extremely divergent views as to what constitutes 'specialist' care; this may go some way to explain why there is variation in how and where many TYA patients are treated. A preference towards one type of care, age or site over another may lead to an increased likelihood of favouring that care setting and a decreased chance of utilisation of other available services.

Wider implications {#s4a}
------------------

This study did not ask respondents whether their attitudes to specialist care would influence their practice but instead focused on the importance assigned to individual aspects of care in the wider picture. In an area such as TYA cancer care, where policy implementation is known to vary by geography and patient demographics, there is a degree of flexibility in terms of patient pathways. The attitude of professionals involved at each stage of the patient\'s journey is likely to at least partly influence the choices made. Unfortunately, in this case it was not possible to assess the extent to which the influence of clinicians varies at different points in the diagnostic and treatment pathways. Understanding the range and strength of opinions is vital before attempting to determine to what extent it influences practice. Policy states that patients should be reviewed by both a TYA and a site-specific MDT, emphasising that these should not be considered mutually exclusive.

Limitations {#s4b}
-----------

This is the first study to examine attitudes towards specialist cancer care in this age group. The method of recruitment to the study (random sampling) may have introduced bias, with those treating a high volume of TYA patients, and those belonging to a medical specialty, being more likely to reply than others. It is not possible to address this issue in a random sample study of this nature; however, the self-reported caseload figures and distribution of medical staff across the clusters ([table 2](#BMJOPEN2012002346TB2){ref-type="table"}) suggest that this has not been a significant problem. A similar issue was also identified regarding the proportion of respondents who identified an affiliation with a CCLG unit, which may have been due to the relatively large number of centres in comparison to TCT centres at the time of the study. Respondents were asked to identify any association between themselves and a specialist unit, including occasional contact, so this does not necessarily mean that this will have resulted in bias in the results.

A large proportion of questions regarding psychosocial support were unanswered; the reasoning behind this is not understood and, owing to the nature of the survey (Likert scale), it was not possible to investigate this in more detail. Additional work could be performed to address this using a more detailed survey assessing these aspects of care.

This study was undertaken in 2009, 5 years after the release of the Improving Outcomes Guidelines, and therefore will be reflective of attitudes to specialist care after the service redesign. Attitudes are likely to have altered since the survey was undertaken; however, the greatest degree of change is likely to have taken place relatively quickly after the publication of the guidance. In order to quantify any further changes in opinion, the study could be performed again, using a similar cohort.

Further work is also now needed to assess to what extent the attitudes of those treating TYA patients with cancer influence their practice, including an analysis of the attitudes of those referring patients for treatment and an assessment of the degree of variation between NHS trusts and cancer networks. In order to assess the different influences which may be affecting the variation in attitudes, such as proximity to a specialist centre and duration of association with a PTC, greater detail regarding the location and affiliation of the respondents would be sought and analysed. Additional work to determine any association between attitude and patient decision-making and variation in attitudes and patient outcomes would also add more detail to the understanding of a complex area.
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